{"url":"https://nivawealth.com/firms/a16z-capital-management-160489","iapdUrl":"https://adviserinfo.sec.gov/firm/summary/160489","regulatoryAum":106476153956,"crd":"160489","secFileNumber":"801-114985","legalName":"A16z Capital Management, L.L.C.","displayName":"A16z Capital Management","website":"http://a16z.com","linkedinUrl":"https://www.linkedin.com/showcase/a16zcrypto/","founded":null,"organization":"Nevada limited liability company","fiscalYearEnd":"December","headquarters":{"street":"2865 Sand Hill Road","city":"Menlo Park","state":"CA","stateName":"California","country":"United States","postalCode":"94025-7022"},"tradeNames":[],"registration":{"secApproved":"11 April 2019","noticeFilings":null,"latestNoticeFiling":null},"staff":{"employees":738,"advisory":88,"brokerDealerReps":0,"insuranceAgents":0,"promoters":0},"aum":{"discretionary":106476153956,"discretionaryAccounts":119,"nonDiscretionary":0,"nonDiscretionaryAccounts":0,"wrapProgram":null,"nonUsClientsPct":0,"nonAumClients":0},"clientTypes":[{"label":"Pooled investment vehicles","clients":119,"regulatoryAum":106476153956}],"fees":[],"feeNotes":[],"feePrograms":[],"brochureCoverage":{"scope":"known_documents","status":"not_processed","checkedAt":null,"documents":[]},"custodians":[],"custodyNote":"A16z Capital Management has custody of client assets.","otherCustodians":[],"leadership":[{"name":"Philip Hathaway","title":"Chief Operating Officer","crd":"7513678"},{"name":"Robert Walker","title":"Chief Compliance Officer","crd":"7552343"},{"name":"Jaikumar Ramaswamy","title":"Chief Legal Officer","crd":"7513397"}],"ownership":[{"label":"A16z Holdings, L.L.C.","detail":"Managing member in the 75% or more ownership band and a control person, since September 2022."},{"label":"Benjamin Horowitz","detail":"Indirect owner: a member of A16z Holdings, L.L.C. in the 50% to 75% band and a control person, since September 2022.","parent":"A16z Holdings, L.L.C."},{"label":"Marc Andreessen","detail":"Indirect owner: a member of A16z Holdings, L.L.C. in the 50% to 75% band and a control person, since September 2022.","parent":"A16z Holdings, L.L.C."}],"branchOffices":null,"filedOffices":{"otherThanPrincipal":4,"privateResidences":0},"listedOfficeAddresses":5,"officesByState":[{"state":"California","offices":3,"addresses":[{"street":"2865 Sand Hill Road","city":"Menlo Park","headquarters":true},{"street":"1305 2nd Street","city":"Santa Monica"},{"street":"180 Townsend ST","city":"San Francisco"}]},{"state":"District of Columbia","offices":1,"addresses":[{"street":"800 17th ST NW, Sixth Floor","city":"Washington"}]},{"state":"New York","offices":1,"addresses":[{"street":"200 Lafayette Street, 3rd Floor","city":"New York"}]}],"advFacts":{"source":{"file":"ia100226.zip","asOf":"2 October 2026"},"telephone":"650-798-5800","stateRegisteredReps":0,"otherAdviserReps":0,"compensation":["A percentage of assets under management","Performance-based fees"],"activities":["Portfolio management for pooled investment vehicles (other than investment companies)"],"financialPlanningClients":null,"assetMix":[],"privateFunds":119},"sources":{"adv1FilingDate":"30 March 2026","adv1Url":"https://reports.adviserinfo.sec.gov/reports/ADV/160489/PDF/160489.pdf","brochureDate":null,"brochureUrl":null,"iapdCompiledDate":null,"retrievedDate":"15 October 2026","retrievedOn":"2026-10-15","adv1Pages":{},"brochurePages":{}},"otherBusiness":[],"faq":[{"question":"How many clients does A16z Capital Management have?","answer":"A16z Capital Management has 119 clients and manages $106.5 billion for them, as of March 2026.","source":"Form ADV Part 1A, Items 5.D and 5.F, filed 30 March 2026","sourceRef":{"doc":"adv1","section":"employees"}},{"question":"What services does A16z Capital Management offer?","answer":"A16z Capital Management provides portfolio management for pooled vehicles.","source":"Form ADV Part 1A, Item 5.G, from the SEC's 2 October 2026 data file","sourceRef":{"doc":"adv1","section":"employees"}},{"question":"How many financial advisors does A16z Capital Management have?","answer":"A16z Capital Management has 0 investment adviser representatives registered with state securities authorities, out of 738 employees, and 88 perform investment advisory functions. None are registered representatives of a broker-dealer or licensed insurance agents.","source":"Form ADV Part 1A, Items 5.A and 5.B, from the SEC's 2 October 2026 data file","sourceRef":{"doc":"adv1","section":"employees"}},{"question":"Who owns A16z Capital Management?","answer":"A16z Capital Management is owned through a holding company by Benjamin Horowitz and Marc Andreessen. Its direct owner is A16z Holdings, L.L.C. (75% or more).","source":"Form ADV Part 1A, Schedules A and B, filed 30 March 2026","sourceRef":{"doc":"adv1","section":"scheduleA"}},{"question":"How does A16z Capital Management get paid?","answer":"A16z Capital Management is paid through a percentage of assets under management and performance-based fees. Its Form ADV lists no commissions among how it is paid.","source":"Form ADV Part 1A, Item 5.E, from the SEC's 2 October 2026 data file","sourceRef":{"doc":"adv1","section":"employees"}}],"holdings":{"url":"https://nivawealth.com/firms/a16z-capital-management-160489/holdings","form":"13F-HR","periodOfReport":"2026-06-30","filedOn":"2026-08-14","filingIndexUrl":"https://www.sec.gov/Archives/edgar/data/1540358/000154035826000010/0001540358-26-000010-index.html","totalValue":14214935834,"positionCount":19,"top10Share":0.9938454776706943,"top10":[{"issuer":"SPACE EXPLORATION TECHN CORP","titleOfClass":"CLASS A COM STK","cusip":"84615Q103","value":12789728717,"shares":74855020,"shareType":"SH"},{"issuer":"NAVAN INC","titleOfClass":"CL A","cusip":"639193101","value":645361120,"shares":28218676,"shareType":"SH","priorValue":373615270,"priorShares":28218676},{"issuer":"REVOLUTION MEDICINES INC","titleOfClass":"COM","cusip":"76155X100","value":172503421,"shares":921099,"shareType":"SH","priorValue":89576878,"priorShares":921099},{"issuer":"META PLATFORMS INC","titleOfClass":"CL A","cusip":"30303M102","value":119716587,"shares":212531,"shareType":"SH","priorValue":121595361,"priorShares":212531},{"issuer":"FIGMA INC","titleOfClass":"CLASS A COM STK","cusip":"316841105","value":108238042,"shares":5983308,"shareType":"SH","priorValue":338480531,"priorShares":16011378},{"issuer":"BIOAGE LABS INC","titleOfClass":"COM","cusip":"09077V100","value":79244997,"shares":3233170,"shareType":"SH","priorValue":56548143,"priorShares":3233170},{"issuer":"BLOCK INC","titleOfClass":"CL A","cusip":"852234103","value":77268972,"shares":1016697,"shareType":"SH","priorValue":61184825,"priorShares":1016697},{"issuer":"ERASCA INC","titleOfClass":"COM","cusip":"29479A108","value":52441000,"shares":2862500,"shareType":"SH","priorValue":46315250,"priorShares":2862500},{"issuer":"MAZE THERAPEUTICS INC","titleOfClass":"COM","cusip":"578784100","value":50794394,"shares":1702225,"shareType":"SH","priorValue":50811416,"priorShares":1702225},{"issuer":"DAMORA THERAPEUTICS INC","titleOfClass":"COM NEW","cusip":"36322Q206","value":32152444,"shares":1236157,"shareType":"SH","priorValue":32016466,"priorShares":1236157}],"positionsListed":19,"positions":[{"issuer":"SPACE EXPLORATION TECHN CORP","titleOfClass":"CLASS A COM STK","cusip":"84615Q103","value":12789728717,"shares":74855020,"shareType":"SH"},{"issuer":"NAVAN INC","titleOfClass":"CL A","cusip":"639193101","value":645361120,"shares":28218676,"shareType":"SH","priorValue":373615270,"priorShares":28218676},{"issuer":"REVOLUTION MEDICINES INC","titleOfClass":"COM","cusip":"76155X100","value":172503421,"shares":921099,"shareType":"SH","priorValue":89576878,"priorShares":921099},{"issuer":"META PLATFORMS INC","titleOfClass":"CL A","cusip":"30303M102","value":119716587,"shares":212531,"shareType":"SH","priorValue":121595361,"priorShares":212531},{"issuer":"FIGMA INC","titleOfClass":"CLASS A COM STK","cusip":"316841105","value":108238042,"shares":5983308,"shareType":"SH","priorValue":338480531,"priorShares":16011378},{"issuer":"BIOAGE LABS INC","titleOfClass":"COM","cusip":"09077V100","value":79244997,"shares":3233170,"shareType":"SH","priorValue":56548143,"priorShares":3233170},{"issuer":"BLOCK INC","titleOfClass":"CL A","cusip":"852234103","value":77268972,"shares":1016697,"shareType":"SH","priorValue":61184825,"priorShares":1016697},{"issuer":"ERASCA INC","titleOfClass":"COM","cusip":"29479A108","value":52441000,"shares":2862500,"shareType":"SH","priorValue":46315250,"priorShares":2862500},{"issuer":"MAZE THERAPEUTICS INC","titleOfClass":"COM","cusip":"578784100","value":50794394,"shares":1702225,"shareType":"SH","priorValue":50811416,"priorShares":1702225},{"issuer":"DAMORA THERAPEUTICS INC","titleOfClass":"COM NEW","cusip":"36322Q206","value":32152444,"shares":1236157,"shareType":"SH","priorValue":32016466,"priorShares":1236157},{"issuer":"OMADA HEALTH INC","titleOfClass":"COM","cusip":"68170A108","value":25322376,"shares":1153639,"shareType":"SH","priorValue":29002560,"priorShares":2307284},{"issuer":"NAUTILUS BIOTECHNOLOGY INC","titleOfClass":"COM","cusip":"63909J108","value":16947911,"shares":9063054,"shareType":"SH","priorValue":68497198,"priorShares":17653917},{"issuer":"ROBLOX CORP","titleOfClass":"CL A","cusip":"771049103","value":14931117,"shares":274570,"shareType":"SH"},{"issuer":"AKTIS ONCOLOGY INC","titleOfClass":"COM","cusip":"01021M104","value":13375450,"shares":415000,"shareType":"SH","priorValue":7424350,"priorShares":415000},{"issuer":"CAMP4 THERAPEUTICS CORP","titleOfClass":"COM","cusip":"13463J101","value":9287731,"shares":2125339,"shareType":"SH","priorValue":9372745,"priorShares":2125339},{"issuer":"BITGO HOLDINGS INC","titleOfClass":"COM SHS CL A","cusip":"091947101","value":3451724,"shares":666356,"shareType":"SH","priorValue":5484110,"priorShares":666356},{"issuer":"KAILERA THERAPEUTICS INC","titleOfClass":"COMMON STOCK","cusip":"482931102","value":3084200,"shares":140000,"shareType":"SH"},{"issuer":"GINKGO BIOWORKS HOLDINGS INC","titleOfClass":"CL A NEW","cusip":"37611X209","value":1075909,"shares":108568,"shareType":"SH","priorValue":665522,"priorShares":108568},{"issuer":"IP STRATEGY HOLDINGS INC","titleOfClass":"COM","cusip":"42727R302","value":9722,"shares":4137,"shareType":"SH"}]},"notice":"Compiled from public SEC Form ADV filings on the dates in `sources`. Facts as filed; not a rating, ranking, or recommendation. Niva Wealth is not affiliated with this firm. Disciplinary history is deliberately not included here or on the page; the SEC publishes the complete record at the `iapdUrl` above."}